Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.21.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 3,547,321 $ 3,498,361 $ 9,275,800 $ 18,755,013
General and administrative 847,134 1,010,006 4,194,103 3,337,422
Total operating expenses 4,394,455 4,508,367 13,469,903 22,092,435
Loss from operations (4,394,455) (4,508,367) (13,469,903) (22,092,435)
Other income (expense):        
Interest income 17,760 16,292 62,047 77,302
Interest expense (7,053) (3,885) (10,654) (6,478)
Local business tax 2 (600) (1,198) (1,800)
Miscellaneous income 670 1,795
Total other income, net 10,709 11,807 50,865 70,819
Loss before income taxes (4,383,746) (4,496,560) (13,419,038) (22,021,616)
Income tax benefit
Net loss $ (4,383,746) $ (4,496,560) $ (13,419,038) $ (22,021,616)
Basic and diluted net loss per share $ (0.04) $ (0.08) $ (0.12) $ (0.42)
Shares used to compute basic and diluted net loss per share 116,262,938 59,670,038 111,748,586 52,706,277